|
Post by kc on Oct 1, 2017 11:44:39 GMT -5
|
|
|
Post by kc on Oct 1, 2017 11:06:59 GMT -5
babaoriley ... looks like your comment is causing some ultra giddiness. You can tell I'm overly giddy by the expression on my avatar. Lizards are not allowed to get Giddy....... EOM.....
|
|
|
Post by kc on Sept 29, 2017 14:50:51 GMT -5
The only thing that is going to drive MNKD is sales.....if the label change is ultra fast hopefully it will drive up sales. Remember, it still has a black box warning...doctors are skittish over lung cancer etc. Convince the docs...no crystal ball, just a little common sense and a look at history. ORLON perhaps you didn't know that every drug has a black box warning. We need to get over that issue. Not a big deal. I don't hear about it causing death.
|
|
|
Post by kc on Sept 29, 2017 14:49:31 GMT -5
I don't care when the announcement is made. Better it be a surprise to the market vs an expectation. The date and time is no matter to this long.
Gomer Pile once said.
SURPRISE, SURPRISE SURPRISE.
|
|
|
Post by kc on Sept 29, 2017 13:47:02 GMT -5
Nice block trade of 100,000 shares at 13:39 this afternoon.
Who was buying it?
|
|
|
Post by kc on Sept 28, 2017 17:36:56 GMT -5
I remember the months leading up to the BP partnership. Every week we saw pps rallies on Thursdays and Fridays. Investors didn't want to miss an after hours announcement. I know the term "squeeze" has been an unfulfilled dream for shareholders but with the current scarcity of available shares it's conceivable that a new class label could propel share price in dollar increments rather than pennies. I know that I over used the term about waking up to news one Monday Pre-market --- SHORTLY.
|
|
|
Post by kc on Sept 28, 2017 11:47:07 GMT -5
Let's hope its going to be approval and the market reacts to it
|
|
|
Post by kc on Sept 25, 2017 18:28:28 GMT -5
Yes it is and I stand by what I said last December - One thing we know for sure is GWPH's pps is north of $100. We also know Teva thinks cannabis needs precision dosing. Another thing we know is Technosphere works. I have no idea how big the CBD market is but I do know how big the afrezza market is. My hope is the RLS announcement brings enough press on MNKD to help jump start afrezza sales. It would be interesting to see Investment by either of those two companies into MannKind
|
|
|
Post by kc on Sept 25, 2017 8:45:02 GMT -5
Why is urbanski still in the slide deck and he mentioned him.
|
|
|
Post by kc on Sept 22, 2017 9:00:18 GMT -5
I sent a copy of that link to Mike C.
|
|
|
Post by kc on Sept 22, 2017 7:02:48 GMT -5
I hope Mike and his team is on top of it.
|
|
|
Post by kc on Sept 20, 2017 12:50:26 GMT -5
The thread is about Afrezza. Anything else? Lol yes Afrezza is inhaled insulin What is it?
|
|
|
Post by kc on Sept 20, 2017 12:47:49 GMT -5
Came across this today on Fidelity.
UPC Restricted (Yes)
Not sure what this really means but Luigi thought it had to so with short positions as outlined on this link. UPC 11830
en.termwiki.com/EN/UPC-11830
UPC-11830
In 1993, the U.S. Securities and Exchange Commission approved a new section of the Uniform Practice Code (UPC) requiring FINRA members to close out short sales in NASDAQ® securities that meet a certain clearing short position threshold. Both NASDAQ National Market® and NASDAQ Small Cap Market securities can be restricted under UPC 11830. Under the rules, the short seller's broker/dealer must close out short sale of specific securities 10 days after normal settlement date if delivery of security has not accrued and the transaction is not exempt. Securities subject to close-out requirement are those with an aggregate "clearing" short position of 10,000 shares or more that equals or exceeds one half of one percent of the total shares outstanding. The FINRA will identify these securities daily based on data from National Securities and Clearing Corporation and compile a "restricted list." Any subsequent short-sale transaction in a security on the list that is not completed by delivery of shares within the prescribed time frames will be subject to mandatory close-out if a "fail-to-deliver" situation exists 10 days after normal settlement date.
The rule applies to customer and proprietary short sales, but exempts "bona fide" market making activities and short sales that results in a "bona fide" fully hedged or arbitraged position. For more information, please see FINRA Notice to Members 93-53.
|
|
|
Post by kc on Sept 14, 2017 18:08:19 GMT -5
Near the close today somebody bought 250,000 shares. Over the last couple years I have looked a big blocks being treated. Lately they have been few and far between.
|
|
|
Post by kc on Sept 13, 2017 15:57:24 GMT -5
Total shares outstanding turned over? They were in share prison and the jail cell has been opened? How do you read it?
I read it as a "reversal of fortune", Granville was big (big in a few ways, size and character RIP) on volume/price action...and supply and demand with shares, so relative to MNKD I like this indicator as we know there has been some pretty good shenanigan's with the supply and demand over the years on this....I think that correlation with the climax reversal low is extremely telling and the positive volume from that point forward ref: stockcharts.com/school/doku.php?id=chart_school:technical_indicators:on_balance_volume_obv I actually had met Joe Granville a couple of times in KC back in the 90's he was a interesting person.
But Joey can you give this to me in English? What is the chart telling you.
|
|